Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Cancer Research

Background:

• Organometallic compounds, particularly copper complexes, are utilized as anticancer agents.
• Topoisomerases are key enzymes in DNA topology regulation and are targets for cancer chemotherapy.
• Understanding the molecular mechanisms of copper-based topoisomerase inhibitors is crucial for drug development.

Purpose of the Study:

• To analyze the distinct molecular mechanisms of copper complex inhibitors targeting topoisomerases 1 and 2.
• To explore the broader synthetic context and relevance to cancer cell mutations.
• To highlight emerging treatment aspects and encourage clinical development of these anticancer drugs.

Main Methods:

• Review and analysis of molecular mechanisms of copper-topoisomerase interactions.
• Examination of DNA break formation, catalytic activity, DNA intercalation, and reactive oxygen species (ROS) production.
• Evaluation of effects on cell cycle checkpoints and cell death pathways.

Main Results:

• Copper complexes exhibit varied mechanisms, including ternary complex formation leading to DNA breaks and catalytic inhibition.
• Some complexes display DNA intercalative properties and induce ROS production.
• These actions impact cell cycle regulation and apoptosis, demonstrating dual effects in some cases.

Conclusions:

• Copper-based topoisomerase inhibitors present diverse and potent anticancer activities.
• Their mechanisms are linked to DNA topology, cell cycle control, and cell death induction.
• Further development and clinical trials are warranted to expand their use in cancer therapy.